juni 10, 2023

Citrate Buffer

Citrate Buffer 

To Order Contact us: bjorn@lembcke.dk

Citrate Buffer(10X), pH 6.0 for Antigen Retriever

C7915-010 100ml
EUR 134.4

Citrate Buffer(10X), pH 6.0 for Antigen Retriever

C7915-050 500ml
EUR 238.8

Saline sodium citrate buffer (SSC) 2x pH 7.0, 1000 ml

12-9196-5 1000 ml
EUR 105.6

Diss Media Diss (USP/EP) Citrate Buffer 0.05M pH 6.00

DB21-10 10L
EUR 249.6

Saline sodium citrate buffer (SSC) 20x pH 7.0, 1000 ml

12-9195-5 1000 ml
EUR 160.8

Buffered Sodium Citrate 3.2 % (0.109M) 100 ml

12-8480-10 100 ml
EUR 111.6

Buffered Sodium Citrate 3.2 % powder (0.109M) 1000 ml

12-8483-5 1000 ml
EUR 148.8

Human citrate(citrate)ELISA Kit

YLA3901HU-48T 48T
EUR 435

Human citrate(citrate)ELISA Kit

YLA3901HU-96T 96T
EUR 562.5

Sodium citrate

B7298-500000 500 g
EUR 134.4

Lithium Citrate

A8462-100000 100 g
EUR 129.6
Description: Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease [1].Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model [2].

Lithium Citrate

A8462-500000 500 g
EUR 296.4
Description: Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease [1].Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model [2].

Alverine Citrate

B1655-25 25 mg
EUR 166.8
Description: Alverine citrate is a drug used for functional gastrointestinal disorders.

Alverine Citrate

B1655-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: Alverine citrate is a drug used for functional gastrointestinal disorders.

Oxeladin Citrate

A8493-1000 1 g
EUR 517.2
Description: Oxeladin Citrate

Oxeladin Citrate

A8493-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Oxeladin Citrate

Oxeladin Citrate

A8493-50 50 mg
EUR 153.6
Description: Oxeladin Citrate

Oxeladin Citrate

A8493-5000 5 g
EUR 1198.8
Description: Oxeladin Citrate

Triethyl citrate

GX1854-100G 100 g
EUR 51.6

Triethyl citrate

GX1854-1KG 1 kg
EUR 82.8

Triethyl citrate

GX1854-250G 250 g
EUR 58.8

Triethyl citrate

GX1854-5KG 5 kg
EUR 226.8

Ixazomib citrate

HY-10452 10mg
EUR 192

Alverine (citrate)

HY-B0500 500mg
EUR 129.6

Oxeladin (citrate)

HY-B1216 100mg
EUR 142.8

Ixazomib Citrate

I030-10MG 10 mg
EUR 202.8

Manganese citrate

abx184167-100g 100 g
EUR 861.6

Tamoxifen Citrate

B1394-10000 10 g
EUR 560.4
Description: Tamoxifen Citrate is an antiestrogen drug [1].Tamoxifen Citrate has been reported to act as an anti-estrogen and inhibit the binding of estrogen to estrogen receptors. Tamoxifen has shown the activity to inhibit tumor growth because of the function of estrogen-antagonist activity in breast tissue.

Tamoxifen Citrate

B1394-5.1 10 mM (in 1mL Ethanol)
EUR 135.6
Description: Tamoxifen Citrate is an antiestrogen drug [1].Tamoxifen Citrate has been reported to act as an anti-estrogen and inhibit the binding of estrogen to estrogen receptors. Tamoxifen has shown the activity to inhibit tumor growth because of the function of estrogen-antagonist activity in breast tissue.

Tamoxifen Citrate

B1394-5000 5 g
EUR 351.6
Description: Tamoxifen Citrate is an antiestrogen drug [1].Tamoxifen Citrate has been reported to act as an anti-estrogen and inhibit the binding of estrogen to estrogen receptors. Tamoxifen has shown the activity to inhibit tumor growth because of the function of estrogen-antagonist activity in breast tissue.

Tamoxifen citrate

1551-1000 each
EUR 196.8

Mosapride Citrate

A1334-100 100 mg
EUR 268.8
Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Mosapride Citrate

A1334-25 25 mg
EUR 157.2
Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Mosapride Citrate

A1334-5 5 mg
EUR 129.6
Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Mosapride Citrate

A1334-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: 5-HT4 receptor agonist and 5-HT3 receptor antagonist. Displays no activity at D2, ?1, ?2, 5-HT1 and 5-HT2 receptors. Gastroprokinetic agent; increases gastric emptyin

Trisodium citrate

abx082608-100g 100 g
EUR 226.8

Tamoxifen Citrate

20-abx076508
  • EUR 292.80
  • EUR 427.20
  • 100 mg
  • 500 mg

Mosapride Citrate

M099-10MG 10mg
EUR 126

Mosapride Citrate

M099-50MG 50mg
EUR 445.2

Mosapride (citrate)

HY-B0189A 10mM/1mL
EUR 135.6

Oxolamine (citrate)

HY-B1042 10mM/1mL
EUR 135.6

Tamoxifen (Citrate)

HY-13757 500mg
EUR 142.8

L-NMMA (citrate)

C5502-100 100 mg
EUR 433.2
Description: L-NMMA (citrate) is a relatively non-selective inhibitor of all NOS isoforms [1].Nitric oxide synthases (NOSs) belong to a family of enzymes involved in catalyzing the production of nitric oxide (NO) from L-arginine.

L-NMMA (citrate)

C5502-25 25 mg
EUR 170.4
Description: L-NMMA (citrate) is a relatively non-selective inhibitor of all NOS isoforms [1].Nitric oxide synthases (NOSs) belong to a family of enzymes involved in catalyzing the production of nitric oxide (NO) from L-arginine.

L-NMMA (citrate)

C5502-50 50 mg
EUR 270
Description: L-NMMA (citrate) is a relatively non-selective inhibitor of all NOS isoforms [1].Nitric oxide synthases (NOSs) belong to a family of enzymes involved in catalyzing the production of nitric oxide (NO) from L-arginine.

PF-543 Citrate

A3718-10 10 mg
EUR 331.2
Description: PF-543 is a novel cell-permeant inhibitor of SphK1. PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.

PF-543 Citrate

A3718-200 200 mg
EUR 2565.6
Description: PF-543 is a novel cell-permeant inhibitor of SphK1. PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.

PF-543 Citrate

A3718-5 5 mg
EUR 212.4
Description: PF-543 is a novel cell-permeant inhibitor of SphK1. PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.

PF-543 Citrate

A3718-50 50 mg
EUR 1034.4
Description: PF-543 is a novel cell-permeant inhibitor of SphK1. PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.

PF-543 (Citrate)

HY-15425A 10mM/1mL
EUR 238.8

Toremifene citrate

B1049-10 each
EUR 170.4

Clomiphene citrate

B1504-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Clomifene Citrate is a selective estrogen receptor modulator.

Clomiphene citrate

B1504-50 50 mg
EUR 153.6
Description: Clomifene Citrate is a selective estrogen receptor modulator.

Clomiphene citrate

B1504-S Evaluation Sample
EUR 97.2
Description: Clomifene Citrate is a selective estrogen receptor modulator.

Toremifene Citrate

B1513-100 100 mg
EUR 129.6
Description: Toremifene Citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body.

Toremifene Citrate

B1513-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Toremifene Citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body.

Carbazeran citrate

B5588-10 10 mg
EUR 265.2

Carbazeran citrate

B5588-50 50 mg
EUR 926.4

Sildenafil Citrate

27105 25 mg
EUR 310
Description: Sildenafil citrate, also known as Revatio, acts by inhibiting cGMP specific phosphodiesterase type 5 (PDE5). The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5.

Sildenafil citrate

2872-10 each
EUR 170.4

Sildenafil citrate

2872-50 each
EUR 496.8

Sildenafil Citrate

A4321-25 25 mg
EUR 129.6
Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Sildenafil Citrate

A4321-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Sildenafil Citrate

A4321-50 50 mg
EUR 170.4
Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Sildenafil Citrate

A4321-500 500 mg
EUR 714
Description: Sildenafil Citrate is a potent inhibitor of cGMP-specific phosphodiesterase including PDE5 with IC50 values of 3.6 nM.[1] PDE5 (cGMP-specific phosphodiesterase type 5) is an enzyme from the phosphodiesterase class.

Piperazine (citrate)

HY-17599 500mg
EUR 129.6

Toremifene (Citrate)

HY-B0005 100mg
EUR 142.8

Clomiphene (citrate)

HY-B0463 500mg
EUR 129.6

Sildenafil citrate

GP3242-1G 1 g
EUR 93.6

Toremifene citrate

GP8497-100MG 100 mg
EUR 93.6

Toremifene citrate

GP8497-1G 1 g
EUR 208.8

Toremifene citrate

GP8497-250MG 250 mg
EUR 122.4

Sildenafil (citrate)

HY-15025A 200mg
EUR 224.4

Citrate Assay Kit

55R-1485 100 assays
EUR 888
Description: Assay Kit for detection of Citrate in the research laboratory

Citrate Assay kit

CIT100 100 assays
EUR 168.93
Description: This product includes 1.5 ml of Reagent A, 1.5 ml of 10 x Reagent B and 0.2 ml of 100 mM ammonium citrate. It is for 100 assays using 96-well plates.

Citrate Assay Kit

abx298835-100Assays 100 Assays
EUR 510

SPD-473 citrate

HY-101612 10mg
EUR 3300

Tofacitinib . citrate

10-047 100 mg
EUR 471.12
Description: Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity. Immunosuppressive and anti-inflammatory agent. Inhibits signaling through heterodimeric receptors associated with JAK3, JAK1, or both of them, with functional selectivity over JAK2-paired receptors. Blocks downstream STAT signaling, resulting in potent inhibition of several cytokines, including interleukins 2, 4, 7, 9, 15 and 21, which are integral to lymphocyte activation, function and proliferation. Investigated for several autoimmune disorders including, rheumatoid arthritis and psoriasis. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). PRK1 inhibitor.

Tofacitinib citrate

GX6522-10MG 10 mg
EUR 151.2

Tofacitinib citrate

GX6522-25MG 25 mg
EUR 265.2

Tofacitinib (citrate)

HY-40354A 10mM/1mL
EUR 151.2

Tasocitinib citrate

TBZ1069 unit Ask for price

KDOAM-25 (citrate)

HY-102047B 10mM/1mL
EUR 211.2

Orphenadrine Citrate

B1606-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Orphenadrine has been used as an antiparkinsonian, antispastic and analgesic drug. Orphenadrine inhibits [3H]MK-801 binding to the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA)-receptor in homogenates of postmortem human frontal cort

Orphenadrine Citrate

B1606-50 50 mg
EUR 153.6
Description: Orphenadrine has been used as an antiparkinsonian, antispastic and analgesic drug. Orphenadrine inhibits [3H]MK-801 binding to the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA)-receptor in homogenates of postmortem human frontal cort

Orphenadrine Citrate

B1606-S Evaluation Sample
EUR 97.2
Description: Orphenadrine has been used as an antiparkinsonian, antispastic and analgesic drug. Orphenadrine inhibits [3H]MK-801 binding to the phencyclidine (PCP) binding site of the N-methyl-D-aspartate (NMDA)-receptor in homogenates of postmortem human frontal cort

Enclomiphene citrate

HY-118861A 5mg
EUR 157.2

Tandospirone (citrate)

HY-B0061 10mM/1mL
EUR 228

Orphenadrine (citrate)

HY-B0369A 10mM/1mL
EUR 151.2

Pentoxyverine Citrate

B1811-100 100 mg
EUR 115.2
Description: Pentoxyverine Citrate is an antitussive (cough suppressant) commonly used for cough associated with illnesses like common cold.

Pentoxyverine Citrate

B1811-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Pentoxyverine Citrate is an antitussive (cough suppressant) commonly used for cough associated with illnesses like common cold.

Bismuth (III) citrate

B0466 100g
EUR 68.35

CP-690550 citrate

9428-25 each
EUR 705.6

CP-690550 citrate

9428-5 each
EUR 248.4

Carbetapentane (citrate)

HY-B1055 500mg
EUR 176.4

Simmons Citrate Agar

MED1466 EACH
EUR 112.8

SIMMONS CITRATE AGAR

S19-111-10kg 10 kg
EUR 1509.6

SIMMONS CITRATE AGAR

S19-111-2Kg 2 Kg
EUR 375.6

SIMMONS CITRATE AGAR

S19-111-500g 500 g
EUR 145.2

Morantel citrate salt

M086-100MG 100 mg
EUR 88.8

Morantel citrate salt

GA4442-1G 1 g
EUR 180

Morantel citrate salt

GA4442-250MG 250 mg
EUR 93.6

Citrate Gold Particles

AuP-002-20 20 mL
EUR 157.2
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Citrate Gold Particles

AuP5-002-20 20 mL
EUR 372
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Zinc citrate dihydrate

GE1507-1KG 1 kg
EUR 165.6

Tamoxifen citrate salt

GP8512-1G 1 g
EUR 170.4

Tamoxifen citrate salt

GP8512-5G 5 g
EUR 505.2

Zinc citrate trihydrate

GE2021-100G 100 g
EUR 60

Zinc citrate trihydrate

GE2021-1KG 1 kg
EUR 151.2

Zinc citrate trihydrate

GE2021-250G 250 g
EUR 74.4

Zinc citrate trihydrate

GE2021-500G 500 g
EUR 103.2

Methyllycaconitine citrate

B6556-10 10 mg
EUR 277.2

Methyllycaconitine citrate

B6556-25 25 mg
EUR 548.4

Methyllycaconitine citrate

B6556-5 5 mg
EUR 186

Methyllycaconitine citrate

B6556-5.1 10 mM (in 1mL DMSO)
EUR 268.8

Methyllycaconitine citrate

B6556-50 50 mg
EUR 946.8

Methyllycaconitine citrate

HY-N2332A 50mg
EUR 734.4

Diethylcarbamazine (citrate)

HY-12642 500mg
EUR 207.6

Ammonium citrate, dibasic

AB0059 500g
EUR 78.79

Sodium citrate, anhydrous

GK2264-100G 100 g
EUR 52.8

Sodium citrate, anhydrous

GK2264-1KG 1 kg
EUR 112.8

Sodium citrate, anhydrous

GK2264-250G 250 g
EUR 64.8

Sodium citrate, anhydrous

GK2264-500G 500 g
EUR 80.4

Sodium citrate, anhydrous

GK2264-5KG 5 kg
EUR 313.2

Sodium citrate dihydrate

GK0137-100G 100 g
EUR 48

Sodium citrate dihydrate

GK0137-1KG 1 kg
EUR 73.2

Sodium citrate dihydrate

GK0137-250G 250 g
EUR 52.8

Sodium citrate dihydrate

GK0137-500G 500 g
EUR 62.4

Sodium citrate dihydrate

GK0137-5KG 5 kg
EUR 170.4

Ammonium bismuth citrate

GX7991-100G 100 g
EUR 108

Ammonium bismuth citrate

GX7991-250G 250 g
EUR 180

Sodium citrate dihydrate

HY-B1610 1g
EUR 142.8

Sodium Citrate pH 3.7, 1 M (100 mL)

M-CSS-526-3.7 100 ml
EUR 97
Description: Sodium Citrate pH 3.7, 1 M (100 mL)

Sodium Citrate pH 4.8, 1 M (100 ml)

M-CSS-526-4.8 100 ml
EUR 97
Description: Sodium Citrate pH 4.8, 1 M (100 ml)

Sodium Citrate pH 5.6, 1 M (100 ml)

M-CSS-526-5.6 100 ml
EUR 97
Description: Sodium Citrate pH 5.6, 1 M (100 ml)

Sodium Citrate pH 6.0, 1 M (100 ml)

M-CSS-526-6 100 ml
EUR 97
Description: Sodium Citrate pH 6.0, 1 M (100 ml)

Citrate Synthase antibody

70R-16610 50 ul
EUR 522
Description: Rabbit polyclonal Citrate Synthase antibody

Citrate synthase Antibody

48284-100ul 100ul
EUR 399.6

Citrate synthase Antibody

48284-50ul 50ul
EUR 286.8

Ammonium citrate, tribasic

AB0060 250g
EUR 72.53

Ammonium citrate tribasic

GL7832-100G 100 g
EUR 67.2

Ammonium citrate tribasic

GL7832-1KG 1 kg
EUR 213.6

Ammonium citrate tribasic

GL7832-250G 250 g
EUR 98.4

Ammonium citrate tribasic

GL7832-25G 25 g
EUR 52.8

Ammonium citrate tribasic

GL7832-500G 500 g
EUR 141.6

Iron(III) citrate hydrate

GK4573-100G 100 g
EUR 60

Iron(III) citrate hydrate

GK4573-1KG 1 kg
EUR 180

Citrate Buffer